What is the future of targeted therapy in rheumatology: biologics or small molecules?
© Mócsai et al.; licensee BioMed Central Ltd. 2014
Received: 14 November 2013
Accepted: 19 February 2014
Published: 13 March 2014
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|14 Nov 2013||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|27 Nov 2013||Reviewed||Reviewer Report - Steffen Gay|
|22 Jan 2014||Reviewed||Reviewer Report - rieke alten|
|19 Feb 2014||Author responded||Author comments - Alessandro Recchioni|
|Resubmission - Version 3|
|19 Feb 2014||Submitted||Manuscript version 3|
|19 Feb 2014||Editorially accepted|
|13 Mar 2014||Article published||10.1186/1741-7015-12-43|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article.. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.